Cibus Announces Important Update to Rice Gene Editing Conversion Rates
Cibus, Inc. - Class A (CBUS)
Company Research
Source: GlobeNewswire
SAN DIEGO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today issued a correction relating to the rice conversion rates previously disclosed in its January 16, 2025 press release. The Company has concluded that the gene editing conversion rates of 10-25% in Rice have not been reconfirmed based upon subsequent experiments and high variability in the conversion rate data. Cibus is continuing to advance its oligonucleotide directed mutagenesis (ODM) editing technologies to drive improved editing conversion rates across its developed traits across its crops of interest. “Notwithstanding the variability experiment to experiment, we continue to believe that Cibus’ standardized high throughput, semi-automated, Rapid Trait Development System™ (RTDS®) will deliver what our customers require, which is edits in their germplasm for trait
Show less
Read more
Impact Snapshot
Event Time:
CBUS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CBUS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CBUS alerts
High impacting Cibus, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
CBUS
News
- Cibus Welcomes the Positive Conclusion of Trilogue Negotiations on New Genomic Techniques Legislation Between the European Parliament and Council [Yahoo! Finance]Yahoo! Finance
- Cibus Welcomes the Positive Conclusion of Trilogue Negotiations on New Genomic Techniques Legislation Between the European Parliament and CouncilGlobeNewswire
- Cibus (NASDAQ:CBUS) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group Inc.. They now have a $15.00 price target on the stock.MarketBeat
- Earnings To Watch: Cibus Inc (CBUS) Reports Q3 2025 Result [Yahoo! Finance]Yahoo! Finance
- Cibus Announces the Election of Craig Wichner to Board of Directors [Yahoo! Finance]Yahoo! Finance
CBUS
Earnings
- 11/13/25 - Miss
CBUS
Analyst Actions
- 12/8/25 - Canaccord Genuity
CBUS
Sec Filings
- 11/25/25 - Form 4
- 11/25/25 - Form 3
- 11/10/25 - Form 8-K
- CBUS's page on the SEC website